Chronic Obstructive Pulmonary Disease (COPD) is a major cause of mortality and morbidity worldwide. It is characterized by airflow limitation caused by an abnormal inflammatory response to noxious particles or gases. COPD is expected to be the third leading cause of death by 2020. Spirometry is important for diagnosing and assessing the severity of COPD. Bronchodilators are central to symptomatic management, with long-acting anticholinergics and long-acting beta agonists as first-line therapy. Combination therapy may provide increased bronchodilation compared to monotherapy.
COPD, or chronic obstructive pulmonary (PULL-mun-ary) disease, is a progressive disease that makes it hard to breathe.Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), and chronic obstructive airway disease (COAD).It provides advice and information about COPD, including what the symptoms are, how it can be treated and what steps you can take to manage your condition.
COPD, or chronic obstructive pulmonary (PULL-mun-ary) disease, is a progressive disease that makes it hard to breathe.Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), and chronic obstructive airway disease (COAD).It provides advice and information about COPD, including what the symptoms are, how it can be treated and what steps you can take to manage your condition.
Reading material on COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) for Nursing students and teachers. It tells pathophysiology, clinical manifestations, diagnostic evaluations, medical and nursing management of COPD.
COPD, EMPHYSEMA, CHRONIC BRONCHITIS,LUNG DISEASE, OBSTRUCTIVE LING DISEASE, PHYSIOLOGY, KINGS COLLEGE,DPT DEPARTMENT ALL necessary information regarding lung disease which you should know
chronic obstructive pulmonary disease and its management
chronic obstructive pulmonary disease is a chronic inflammatory lung disease that causes obstructed airflow from the lungs.
COPD typically has a clear cause and a clear path of prevention, and there are ways to slow the progression of the disease.
COPD is a lung disease that makes it hard to breathe. It is caused by damage to the lungs over many years, usually from smoking.
The main symptoms are:
• A long-lasting (chronic) cough.
• Mucus that comes up when you cough.
• Shortness of breath that gets worse when you exercise.
We would like to intoduce you with BREATHE FREE!
Read more on it, See: http://www.nirogam.com/product_detail/333/Breathe-Free-60-Capsules-(Organic)
We are committed to your wellness and promise to help you with any health concern you may have. Please feel free to contact us via email or phone.
Nirogam India Pvt. Ltd.
F-32 & 33, 1st Floor
DLF Centre Point, Sector – 11,
Bata Mor, Main Mathura Road,
Faridabad, Haryana (India) - 121006
Mob: +91-9958171405 # 9015525552
Ph: 0129-4076777, 4006805
Email: support@nirogam.com
Facebook: www.facebook.com/nirogam
Web: www.nirogam.com
Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease which is characterized by breathing problems and poor airflow. The main symptoms of this disease are shortness of breath and cough with sputum production. COPD is a progressive disease and it typically worsens gradually.
This is a brief presentation about COPD. If you have been prescribed oxygen therapy, you may have COPD. It talks about the symptoms, causes and treatment levels.
The Presentation also talks about AirSep Oxygen Concentrators. Further details about AirSep concentrators and their availability in India can be found out at http://www.respirent.com/our_products_oxygen_concentrators.html
Reading material on COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE) for Nursing students and teachers. It tells pathophysiology, clinical manifestations, diagnostic evaluations, medical and nursing management of COPD.
COPD, EMPHYSEMA, CHRONIC BRONCHITIS,LUNG DISEASE, OBSTRUCTIVE LING DISEASE, PHYSIOLOGY, KINGS COLLEGE,DPT DEPARTMENT ALL necessary information regarding lung disease which you should know
chronic obstructive pulmonary disease and its management
chronic obstructive pulmonary disease is a chronic inflammatory lung disease that causes obstructed airflow from the lungs.
COPD typically has a clear cause and a clear path of prevention, and there are ways to slow the progression of the disease.
COPD is a lung disease that makes it hard to breathe. It is caused by damage to the lungs over many years, usually from smoking.
The main symptoms are:
• A long-lasting (chronic) cough.
• Mucus that comes up when you cough.
• Shortness of breath that gets worse when you exercise.
We would like to intoduce you with BREATHE FREE!
Read more on it, See: http://www.nirogam.com/product_detail/333/Breathe-Free-60-Capsules-(Organic)
We are committed to your wellness and promise to help you with any health concern you may have. Please feel free to contact us via email or phone.
Nirogam India Pvt. Ltd.
F-32 & 33, 1st Floor
DLF Centre Point, Sector – 11,
Bata Mor, Main Mathura Road,
Faridabad, Haryana (India) - 121006
Mob: +91-9958171405 # 9015525552
Ph: 0129-4076777, 4006805
Email: support@nirogam.com
Facebook: www.facebook.com/nirogam
Web: www.nirogam.com
Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease which is characterized by breathing problems and poor airflow. The main symptoms of this disease are shortness of breath and cough with sputum production. COPD is a progressive disease and it typically worsens gradually.
This is a brief presentation about COPD. If you have been prescribed oxygen therapy, you may have COPD. It talks about the symptoms, causes and treatment levels.
The Presentation also talks about AirSep Oxygen Concentrators. Further details about AirSep concentrators and their availability in India can be found out at http://www.respirent.com/our_products_oxygen_concentrators.html
The latest guidelines on the management of a COPD patient ( Stable COPD, patient with an exacerbation of COPD), latest modalities of treatment of a COPD patient
Presentation on Treatment of Bronchial Asthma | Jindal Chest ClinicJindal Chest Clinic
Bronchial asthma is a lung disease characterized by inflammation, narrowing, swelling of airways, and increased mucus production, making it difficult to breathe. This Presentation gives an overview on "Treatment of Bronchial Asthma" including management, diagnosis, symptoms, Complications, etc. For more information, please contact us: 9779030507.
I am professionally pharmacist. These slides provide for pharmacy department student. Especially related clinical subject and discussion about disease.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
2. Why COPD is Important ?
COPD is the only chronic disease that is showing
progressive upward trend in both mortality and
morbidity
It is expected to be the third leading cause of death
by 2020
Approximately 14 million Indians are currently
suffering form COPD*
Currently there are 94 million smokers in India
10 lacs Indians die in a year due to smoking related
diseases
*The Indian J Chest Dis & Allied Sciences 2001; 43:139-47
3. Disease Trajectory of a
Patients with COPD
Symptoms
Exacerbations
Exacerbations
Deterioration
Exacerbations
End of Life
4. “Despite this burden, COPD is
a “Cindrella” conditions that
receives limited recognition
from both patients and
physicians”
Respiratory Medicine 2002; 96: S1-S31
5. Obstructive Airway Disease
Asthma COPD
Explosion in Little research
research (? neglect)
Revolution in Few advances in
therapy
therapy
6. New Definition
Chronic obstructive pulmonary disease (COPD) is
a preventable and treatable disease state
characterised by airflow limitation that is not fully
reversible.
The airflow limitation is usually progressive and is
associated with an abnormal inflammatory
response of the lungs to noxious particles or
gases, primarily caused by cigarette smoking.
Although COPD affects the lungs, it also produces
significant systemic consequences.
ATS/ERS 2004
7. Risk Factors
Smoke from home cooking and heating
fuel
Occupational dust and chemicals
Gender: More common in men. M:F
ratio is 5%:2.7% (in India)
Increasing age
Others: Infection, nutrition and
deficiency of α1 antitrypsin
8. Pathophysiology of COPD
Increased mucus production and
reduced mucociliary clearance -
cough and sputum production
Loss of elastic recoil - airway
collapse
Increase smooth muscle tone
Pulmonary hyperinflation
Gas exchange abnormalities -
hypoxemia and/or hypercapnia
9. Key Indicators for COPD Diagnosis
Chronic cough Present intermittently or every day
often present throughout the day;
seldom only nocturnal
Chronic sputum production Present for many years, worst in
winters. Initially mucoid – becomes
purulent with exacerbation
Dyspnoea that is Progressive (worsens over time)
Persistent (present every day)
Worse on exercise
Worse during respiratory infections
Acute bronchitis Repeated episodes
History of exposure to risk Tobacco smoke (including beedi)
factors occupational dusts and chemical
smoke from home cooking and
heating fuel
10. Physical signs
Large barrel shaped
chest (hyperinflation)
Prominent accessory
respiratory muscles in
neck and use of
accessory muscle in
respiration
Low, flat diaphragm
Diminished breath sound
11. Algorithm for Diagnosis at Primary Care
Pt reporting with respiratory symptoms
Assess by
- H/o exposure to risk factors
- Physical examination
Sputum for AFB
+ve -ve
Treat as TB Provisional Diagnosis
of COPD
Treat as COPD Poor response refer
to secondary care
National Guidelines for Management of COPD at Primary Care Level
13. Spirometry
FEV1 – Forced expired volume in the
first second
FVC – Total volume of air that can be
exhaled from maximal inhalation to
maximal exhalation
FEV1/FVC% - The ratio of FEV1 to
FVC, expressed as a percentage.
14. COPD classification based on spirometry
GOLD 2003
Severity Postbronchodilator Postbronchodilator
FEV1/FVC FEV1% predicted
At risk >0.7 >80
Mild COPD <0.7 >80
Moderate COPD <0.7 50-80
Severe COPD <0.7 30-50
Very severe <0.7 <30
COPD
SPIROMETRY is not to substitute for clinical judgment in the
evaluation of the severity of disease in individual patients.
18. How Do Bronchodilators Work?
Reverse the increased
bronchomotor tone
Relax the smooth muscle
Reduce the hyperinflation
Improve breathlessness
19. “All guidelines recommend inhaled
bronchodilator as first line therapy.
The ATS suggest initial therapy with
an anticholinergic drug if regular
therapy is needed”
Chest 2000; 117: 23S-28S
20. Mode of Action
Cholinergic tone is the only
reversible component of COPD
Normal airway have small
degree of vagal cholinergic
tone (no perceptible effect
due to patent airways)
21. Mode of Action (Contd.)
Airways are narrowed in COPD
therefore vagal cholinergic tone has
greater effect on airway resistance
(Resistance
α1/radius4)
Therefore, the need for
anticholinergic drugs that will act as
muscarinic receptor antagonist and
block the acetylcholine induced
bronchoconstriction
22. Mode of Action (Contd.)
Anticholinergics may also reduce
mucus hypersecretion
Anticholinergic have no effect on
pulmonary vessels, and therefore do
not cause a fall in PaO2
Drugs of Today 2002; 38(9): 585-600
23. “Patients with moderate to severe symptoms of
COPD require combination of
bronchodilators”
“Combining bronchodilators with different
mechanisms and durations of actions may
increase the degree of bronchodilation for
equivalent or lesser side effects’’
GOLD Report 2003
24. Algorithm for the management of COPD
Mild Short acting bronchodilator – as required
assess with symptoms and spirometry
Tiotropium Long acting beta agonist
Tiotropium+LABA LABA + tiotropium
Add
-Inhaled steroids
Severe -Theophylline